从古老传说到现代科技，人类对抗衰老的追求贯穿文明史。过去，这是一门介于 "富人黑科技试 验"与"模糊保健品承诺"之间的半科学生意，而当数据、AI逐渐取代玄学叙事，一个更加清晰的抗衰 商业时代正在到来。 随着中国步入 "超级老龄化"阶段， 毕马威 研究显示 2035年中国抗衰老产业市场规模将 突破 4.6 万亿元 。然而，行业多年未能完成真正的 "规模化"，核心原因并不在需求而在供给，缺乏低门槛、 标准化的工具。 在此背景下，美年健康基于亿级健康数据和前沿 AI算法，推出国内首个依托常规体检指标计算衰老 程度的 AI 产品——"血液学时钟"。 它的意义不止于技术突破，更可能是改写行业格局的 "里程碑事件"：抗衰首次从高端人群渗透到大 众市场，从高成本实验室技术转为规模化、普惠的体检场景服务。 这也是美年迈向数智化健康管理的关键跨越。通过盘活常规体检数据，在扩大用户规模的同时，也能 将低频的单次体检升级为可持续的长期收益，美年正 打开 "第二增长曲线"。 抗衰市场迎破局点 "抗衰"已并非新鲜话题，但其商业市场正首次迎来"需求加速、供给可规模化"的破局点。 在需求端，一场由政策、人口与消费心智驱动的 "完美风暴"正 ...

Core Viewpoint - The launch of the "Hematological Clock" product by Meinian Health represents a significant step in the company's innovation strategy, aimed at enhancing its commercial competitiveness through AI-based biological age assessment using routine health check data [1][3]. Group 1: Product Launch and Development - Meinian Health introduced the "Hematological Clock" at a press conference in Shanghai, marking a key milestone in its innovation strategy [1]. - The product is designed to address the gap in traditional health check-ups, which primarily focus on disease screening rather than aging assessment and health span extension [3]. - The development of aging assessment technology has evolved over time, with the "Hematological Clock" being a culmination of years of research and collaboration with Fipeng Bio [3][4]. Group 2: Technical and Scientific Basis - The product leverages over 200 million health check data points, utilizing a dataset of 300,000 anonymized health check records across various demographics to build its predictive model [4][5]. - An innovative algorithm system was developed to extract "aging signals" from health check data, enabling accurate biological age predictions [5]. Group 3: Competitive Advantages - The "Hematological Clock" sets a new industry standard with its unique technical architecture, achieving a Pearson correlation coefficient of 0.896 between predicted biological age and actual age, with a mean absolute error of only 2.90 [6]. - The product is designed for accessibility, allowing users to upload routine health check reports without the need for additional tests, thus lowering barriers to anti-aging assessments [6][7]. Group 4: Target Audience and Market Potential - The target audience includes health-conscious young adults, practitioners of anti-aging interventions, individuals seeking quality longevity, and those at risk of chronic diseases [7]. - The product not only enhances consumer package offerings but also provides customized solutions for B2B clients, creating diverse revenue opportunities [7]. Group 5: Future Development Strategy - Meinian Health outlined a three-step strategy for future product development, focusing on optimizing the current "Hematological Clock," integrating multimodal data, and eventually launching a comprehensive "multi-omics digital health clock" [8][9]. - The long-term vision is to establish a one-stop service ecosystem for anti-aging that combines in-depth health checks, precise assessments, and personalized interventions [9].